1. Home
  2. CPIX vs TNXP Comparison

CPIX vs TNXP Comparison

Compare CPIX & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • TNXP
  • Stock Information
  • Founded
  • CPIX 1999
  • TNXP 2007
  • Country
  • CPIX United States
  • TNXP United States
  • Employees
  • CPIX N/A
  • TNXP N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPIX Health Care
  • TNXP Health Care
  • Exchange
  • CPIX Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • CPIX 17.2M
  • TNXP 19.5M
  • IPO Year
  • CPIX 2009
  • TNXP N/A
  • Fundamental
  • Price
  • CPIX $2.36
  • TNXP $0.37
  • Analyst Decision
  • CPIX
  • TNXP Strong Buy
  • Analyst Count
  • CPIX 0
  • TNXP 2
  • Target Price
  • CPIX N/A
  • TNXP $53.50
  • AVG Volume (30 Days)
  • CPIX 5.5M
  • TNXP 186.1M
  • Earning Date
  • CPIX 11-07-2024
  • TNXP 11-12-2024
  • Dividend Yield
  • CPIX N/A
  • TNXP N/A
  • EPS Growth
  • CPIX N/A
  • TNXP N/A
  • EPS
  • CPIX N/A
  • TNXP N/A
  • Revenue
  • CPIX $36,785,442.00
  • TNXP $11,291,000.00
  • Revenue This Year
  • CPIX N/A
  • TNXP $62.53
  • Revenue Next Year
  • CPIX N/A
  • TNXP $26.17
  • P/E Ratio
  • CPIX N/A
  • TNXP N/A
  • Revenue Growth
  • CPIX N/A
  • TNXP 183.05
  • 52 Week Low
  • CPIX $1.04
  • TNXP $0.12
  • 52 Week High
  • CPIX $3.05
  • TNXP $21.76
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 66.16
  • TNXP 62.63
  • Support Level
  • CPIX $2.07
  • TNXP $0.18
  • Resistance Level
  • CPIX $2.93
  • TNXP $1.30
  • Average True Range (ATR)
  • CPIX 0.26
  • TNXP 0.11
  • MACD
  • CPIX 0.08
  • TNXP 0.02
  • Stochastic Oscillator
  • CPIX 53.06
  • TNXP 17.41

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: